Summary
1Q (Apr–Jun) revenue rose +29.0%, driven by the first consolidated contribution from Oyo Koken Kogyo and strong demand for semiconductor-related optical components. The order backlog climbed to JPY 7,877M, up +18.7% from the prior fiscal year-end. The primary focus for 2Q is progress against the 1H plan (operating income of JPY 730M). We will also watch how far losses narrow in the Inspection Equipment business, where management says "revenue will be concentrated in 2Q and beyond." Gross profit margin fell from 35.5% to 32.1% in 1Q, and its trajectory will show whether cost overruns and order-related expenses were truly one-off. On September 29, the company unveiled its new medium-term management plan, "NIRECO-VISION 100," and raised full-year guidance to revenue of JPY 13.2B and operating income of JPY 2B. 2Q results will be the first progress check on a growth story anchored by the Optics business.
Key Points for Next Quarter
| Key Points & Focus | Implications |
|---|---|
1H Plan AchievementAchievement rate of 2Q cumulative revenue and operating income vs. the 1H plan | Subtracting 1Q actuals from the 1H plan implies standalone 2Q (three-month) operating income of JPY 494M, below the JPY 583M posted in the year-ago quarter (our estimate). Beating the plan would raise confidence in the upwardly revised full-year operating income target of JPY 2,000M. |
Growth DriverOptics revenue, segment profit and order backlog | 1Q revenue was JPY 1,077M (+81.8%) and segment profit JPY 320M (+88.1%). The order backlog of JPY 3,140M (+20.7% vs. prior fiscal year-end) indicates whether high growth can be sustained in the core business of the medium-term plan. |
Margin RecoveryInspection Equipment segment P&L and backlog conversion | 1Q segment loss widened to JPY 218M from JPY 82M a year earlier. The key question is whether conversion of the JPY 1,271M backlog (+82.2% vs. prior fiscal year-end) brings the segment closer to the full-year profitability the company expects. |
ProfitabilityGross profit margin trend YoY and QoQ | 1Q gross profit margin was 32.1%, down from 35.5% a year earlier (our estimate). The extent of recovery toward the 44.9% achieved in standalone 2Q last year (our estimate) will show whether cost pressures were temporary. |
Order TrendsConsolidated and segment order backlog trends | The 1Q-end order backlog stood at JPY 7,877M (+18.7% vs. prior fiscal year-end). Whether it stays elevated at 2Q-end will underpin the revised 2H revenue outlook. |
Key Issues from Previous Results (FY3/27 1Q Results)
1Q delivered higher revenue and profit, with revenue of JPY 2,945M (+29.0%) and operating income of JPY 236M (+63.2%). Management described performance as "broadly in line with plan." On September 29, the company announced a new medium-term management plan ending FY3/31 and raised full-year guidance. 2Q results will be assessed on three axes: progress against the 1H plan, sustainability of Optics growth, and margin recovery in Inspection Equipment.
1. 1H Plan Achievement and Standalone 2Q Profit Level
- Previous Quarter: 1Q revenue of JPY 2,945M represented 50.8% of the 1H plan of JPY 5,800M. Operating income of JPY 236M represented 32.3% of the 1H plan of JPY 730M (our estimate).
- This Quarter Check: Backing out from the 1H plan, standalone 2Q requires revenue of JPY 2,855M and operating income of JPY 494M (our estimate). The company revised full-year guidance on September 29, but the 1H plan is based on figures from the 1Q earnings release. Whether it has been revised will be confirmed with 2Q results.
- Key Metrics: 2Q cumulative operating income vs. the 1H plan of JPY 730M, and vs. prior-year standalone 2Q operating income of JPY 583M.
2. Sustainability of Optics Growth
- Previous Quarter: Demand for optical components used in semiconductor manufacturing and inspection equipment was "very strong," lifting 1Q revenue to JPY 1,077M (+81.8%).
- Previous Quarter: Segment profit reached JPY 320M (+88.1%), with segment margin expanding from 28.7% to 29.7% (our estimate).
- This Quarter Check: We will monitor the pace at which the JPY 3,140M backlog (+20.7% vs. prior fiscal year-end) converts to revenue, and whether laser equipment sales continue to contribute. With Optics positioned as the core growth engine of the new medium-term plan, 2Q results could directly shape how the market views the plan.
- Key Metrics: YoY change in Optics 2Q cumulative revenue and segment profit, and change in 2Q-end backlog vs. prior fiscal year-end.
3. Inspection Equipment Margin Recovery and Path to Full-Year Profitability
- Previous Quarter: 1Q segment loss widened to JPY 218M from JPY 82M a year earlier. Management attributed this "temporary" deterioration to cost overruns on certain projects and higher order-related expenses.
- Previous Quarter: Inquiries rose for plain web inspection systems, electrode inspection systems and AI-based food inspection systems, lifting the backlog to JPY 1,271M (+82.2% vs. prior fiscal year-end).
- This Quarter Check: Management expects revenue to be concentrated in 2Q and beyond, so the focus is whether standalone 2Q losses narrow or turn to profit. The revenue contribution from the "BCON6000" print quality inspection system, launched in September, will mainly be a checkpoint from 3Q onward.
- Key Metrics: Inspection Equipment 2Q cumulative segment P&L and standalone 2Q P&L (the difference from the 1Q loss of JPY 218M), and backlog conversion.
4. Gross Profit Margin Recovery and Cost Structure
- Previous Quarter: Although 1Q revenue grew +29.0%, gross profit margin fell from 35.5% to 32.1% (our estimate). The provision for construction contract losses rose from JPY 42M at the prior fiscal year-end to JPY 49M.
- Previous Quarter: SG&A was JPY 708M (+6.5%, our estimate), and operating income margin improved from 6.4% to 8.0% (our estimate).
- This Quarter Check: We will assess whether Inspection Equipment cost overruns and order-related expenses persist into 2Q, or are absorbed by an improved sales mix. In 1Q, recurring profit grew +56.6% while net income rose only +41.6%. We will review the breakdown of income taxes and profit attributable to non-controlling interests.
- Key Metrics: Standalone 2Q gross profit margin vs. 44.9% in standalone 2Q last year and 32.1% in 1Q (both our estimates).
5. Backlog Trends and Consistency with the Revised Full-Year Plan
- Previous Quarter: The 1Q-end order backlog was JPY 7,877M (+18.7% vs. prior fiscal year-end). Control Equipment backlog was JPY 3,280M (+2.1%).
- Previous Quarter: Within Control Equipment, the functional film and flexible packaging segment remained weighed down by weakness in secondary battery-related demand, with profit of JPY 79M (-32.7%).
- This Quarter Check: Backing out from the revised full-year guidance (revenue of JPY 13,200M, operating income of JPY 2,000M) and the 1H plan, 2H requires revenue of JPY 7,400M and operating income of JPY 1,270M (our estimate). This exceeds last year's 2H revenue of JPY 5,971M and operating income of JPY 973M. The key question is whether the 2Q-end backlog supports these targets.
- Key Metrics: Consolidated and segment 2Q-end backlog vs. prior fiscal year-end, and 2Q cumulative progress against revised full-year guidance.
Key Timely Disclosures This Quarter
- 2026/10/30Notice Regarding Acquisition of Shares of YGK (Conversion into a Subsidiary) - The Board resolved to acquire shares of YGK and make it a subsidiary.
- 2026/09/29Formulation of New Medium-Term Management Plan "NIRECO-VISION 100" and Revision of FY3/27 Full-Year Guidance - The plan targets revenue of JPY 17B, operating income of JPY 3.3B and an operating income margin of 19.4% in FY3/31, with Optics at the core of growth. Full-year guidance was raised to revenue of JPY 13.2B and operating income of JPY 2B, making 2Q results the first progress check.
- 2026/09/01Launch of "BCON6000" High-Speed, High-Definition Print Quality Inspection System - Building on a track record of approximately 220 units sold of its predecessor BCON5000, the company targets cumulative sales of 100 units over three years. This should strengthen the medium-term revenue base of Inspection Equipment, though its P&L contribution will be a checkpoint from 3Q onward.
Previous Quarter Results (FY3/27 1Q Actual)
NIRECO CORPORATION is a measurement and control equipment manufacturer built on core technologies in image processing, sensing and optics. Through its three businesses (Control Equipment, Inspection Equipment and Optics), it helps production sites "measure, detect, and adjust." 1Q revenue rose +29.0%, driven by demand for optical components used in semiconductor manufacturing and inspection equipment, plus the contribution from Oyo Koken Kogyo, consolidated from 4Q of the prior fiscal year. Operating income grew +63.2%, absorbing a temporary widening of losses in Inspection Equipment. The new medium-term management plan "NIRECO-VISION 100," announced on September 29, targets an operating income margin of 19.4% in FY3/31, up from 15.4% in the prior fiscal year (our estimate).
| Item | Amount | YoY | vs. Company Plan | Notes |
|---|---|---|---|---|
| Revenue | JPY 2,945M | +29.0% | - | Optics +81.8%, plus consolidated contribution from Oyo Koken Kogyo. Progress vs. 1H plan of 50.8% (our estimate) |
| Operating Income | JPY 236M | +63.2% | - | Gross profit margin fell to 32.1%; Inspection Equipment posted a segment loss of JPY 218M. Progress vs. 1H plan of 32.3% (our estimate) |
| Recurring Profit | JPY 278M | +56.6% | - | Non-operating expenses fell from JPY 12M to JPY 1M as FX losses disappeared |
| Net Income Attributable to Owners of Parent Company (Quarterly) | JPY 149M | +41.6% | - | No extraordinary gains or losses recorded |
| EPS | JPY 6.97 | +46.7% | - | Retroactively adjusted for the 3-for-1 stock split effective August 1, 2026 |
Guidance Achievement Rate (Recurring Profit Basis): 13.9% (prior year: 9.9%). Our estimate uses the full-year recurring profit plan of JPY 2,000M as of the 1Q earnings release as the denominator. The prior-year ratio is calculated against the prior fiscal year's actual of JPY 1,794M. The recurring profit plan following the September 29 guidance revision will be confirmed with 2Q results.
ENVALITH, INC. ("ENVALITH") provides exclusive research coverage services to domestic and international institutional investors, as well as domestic individual investors, with the objective of contributing to the development of global and Japanese capital markets by providing information necessary for considering investments in Japanese listed companies.
- Purpose and Disclaimer Regarding Investment Decisions
This report has been prepared solely for informational purposes and does not constitute a solicitation to acquire, sell, or hold securities or any other financial products. Furthermore, this report does not constitute specific investment, financial, or tax advice. Any opinions, judgments, or recommendations contained herein are not intended to induce investment activities. Please be advised that all investment decisions must be made based on the investor's own responsibility and judgment, and ENVALITH and subject company shall not be involved in any such investment decisions.
- Information Sources, Accuracy, and Disclaimer of Warranty
This report has been prepared based on a formal request from the subject company, utilizing information provided by and interviews conducted with said company. By using this report, you are deemed to have agreed to the following: 1. Information Sources: This report is prepared on the assumption that the publicly available information and information disclosed by the subject company and provided during interviews is true and reliable. ENVALITH has not independently verified or validated the veracity of such information. 2. Accuracy: The interpretations, analyses, and hypotheses or conclusions based thereon contained in this report are independently derived by ENVALITH using its own perspectives and analytical methods based on the information mentioned in the preceding paragraph. 3. Disclaimer of Warranty: In the event that there are errors or omissions in the information disclosed by the subject company, ENVALITH and subject company shall not be held liable for any inaccuracies in this report resulting therefrom. ENVALITH and subject company make no warranties, whether express or implied, regarding the accuracy, safety, validity, completeness, or any other aspect of this report, nor regarding the past or future performance of the subject company.
- Limitation of Liability
ENVALITH and subject company shall not be liable for any costs, damages, or losses (including direct, indirect, incidental, consequential, or punitive damages) arising from the use of this report or the information obtained therefrom. Users of this report acknowledge and agree that such use is at their own risk.
- Potential Conflicts of Interest
ENVALITH may have, or may have in the future, business relationships with the subject company. Accordingly, investors should be aware that conflicts of interest may exist that could affect the objectivity of this report.
- No Obligation to Change or Update Content
The contents and opinions in this report, as well as the information upon which it is based, are current as of the date of preparation and are subject to change without notice. Please be advised that ENVALITH is under no obligation to update the contents of this report, and investors must verify the timeliness of the information on their own.
- Governing Language
This report is prepared in Japanese, English, and Chinese. In the event of any discrepancy or difference in interpretation between the language versions, the Japanese version shall be treated as the original and shall prevail.
- Copyright
All rights (including copyrights) relating to this report belong to ENVALITH. Any reproduction, redistribution, or other use of all or part of this report without the prior written permission of ENVALITH is strictly prohibited.
- Use for Other Investment Products
Except where ENVALITH has provided prior written approval, the use of this report and the trademarks or trade names of ENVALITH or the subject company in connection with the information distribution, transaction, sales promotion, or advertising of any investment products (including derivatives, structured products, investment trusts, or investment assets whose price, return, or performance is based on or linked to this report) is strictly prohibited.